Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Pathology & Laboratory Medicine and Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinatti, Ohio.
Ann Allergy Asthma Immunol. 2018 Aug;121(2):179-185. doi: 10.1016/j.anai.2018.05.014. Epub 2018 May 24.
To describe key diagnostic considerations in patients with pulmonary infiltrates with eosinophilia, with a special emphasis on raising awareness of hypereosinophilic syndrome (HES), a disease that often involves the lungs and prompts investigation for clonal neoplastic processes that determine prognosis and treatment.
Studies and review articles were selected from PubMed and Scopus for relevance to pertinent topics.
The literature was screened for studies that described lung eosinophilia and HES. Studies relevant to the topic were included in this review.
Pulmonary eosinophil infiltrates in lung biopsy specimens present a broad differential diagnosis, including eosinophilic pneumonia; hypersensitivity reactions, such as allergic bronchopulmonary fungal disease; and pulmonary manifestations of systemic diseases, such as eosinophilic granulomatosis with polyangiitis. An additional important consideration in the differential diagnosis is pulmonary involvement by HES. HES is a rare syndrome that comprises a heterogeneous group of conditions characterized by persistent blood and/or tissue eosinophilia associated with organ dysfunction. Approximately one-third of HES cases are caused by neoplastic diseases, with the remaining cases classified as reactive or idiopathic. Lung involvement is seen in up to 67% of cases and may be the presenting manifestation of the disorder.
The differential diagnosis of pulmonary eosinophilia is broad and requires a multidisciplinary approach with clinicopathologic-radiologic correlation.
描述肺浸润伴嗜酸性粒细胞增多患者的主要诊断注意事项,特别强调嗜酸性粒细胞增多综合征(HES)的认识,该病常累及肺部,并促使对决定预后和治疗的克隆性肿瘤过程进行调查。
从 PubMed 和 Scopus 中选择了与相关主题相关的研究和综述文章。
对描述肺嗜酸性粒细胞增多和 HES 的研究进行了筛选。与该主题相关的研究被纳入本综述。
肺活检标本中的肺嗜酸性粒细胞浸润呈现广泛的鉴别诊断,包括嗜酸性肺炎;过敏反应,如变应性支气管肺真菌病;以及系统性疾病的肺部表现,如嗜酸性肉芽肿性多血管炎。鉴别诊断中另一个重要的考虑因素是 HES 引起的肺部受累。HES 是一种罕见的综合征,由一组异质性疾病组成,其特征为持续性血液和/或组织嗜酸性粒细胞增多,并伴有器官功能障碍。大约三分之一的 HES 病例由肿瘤疾病引起,其余病例归类为反应性或特发性。肺部受累见于多达 67%的病例,并且可能是该疾病的首发表现。
肺嗜酸性粒细胞增多的鉴别诊断广泛,需要多学科方法,结合临床病理-放射学相关性。